An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

Cell Metabolism

Volumn 27, Issue 3, 2018, Pages 559-571.e5

  Mardinoglu, Adil ^a,b   Wu, Hao ^c   Bjornson, Elias ^b,c   Zhang, Cheng ^a   Hakkarainen, Antti ^d   Räsänen, Sari M ^e   Lee, Sunjae ^a   Mancina, Rosellina M ^c   Bergentall, Mattias ^c   Pietiläinen, Kirsi H ^d,e   Söderlund, Sanni ^e   Matikainen, Niina ^d,e   Ståhlman, Marcus ^c   Bergh, Per Olof ^c   Adiels, Martin ^c   Piening, Brian D ^f   Granér, Marit ^e   Lundbom, Nina ^d   Williams, Kevin J ^c   Romeo, Stefano ^c   Nielsen, Jens ^b   Snyder, Michael ^f   Uhlén, Mathias ^a   Bergström, Göran ^c   Perkins, Rosie ^c   Marschall, Hanns Ulrich ^c   Bäckhed, Fredrik ^c   Taskinen, Marja Riitta ^e   Borén, Jan ^c   more..

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f STANFORD UNIVERSITY   (United States)

Author keywords

carbohydrate restricted diet; FGF21; folate; inflammation; microbiome; multi omics; NAFLD; PPAR ; Streptococcus; oxidation

Indexed keywords

3 HYDROXYBUTYRIC ACID; FOLIC ACID;

ADULT; ARTICLE; CARBON METABOLISM; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; COHORT ANALYSIS; DOWN REGULATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LIPOGENESIS; LIVER BIOPSY; LOW CARBOHYDRATE DIET; MALE; METABOLOMICS; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN CONTENT; STREPTOCOCCUS; TRANSCRIPTOMICS; UPREGULATION; DIET THERAPY; LIPID METABOLISM; METABOLISM; PROCEDURES;

COHORT STUDIES; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; FOLIC ACID; GASTROINTESTINAL MICROBIOME; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 85041993278     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2018.01.005     Document Type: Article

References (109)

1. Akesson, B., Fehling, C., Jagerstad, M., Stenram, U., Effect of experimental folate deficiency on lipid metabolism in liver and brain. Br. J. Nutr. 47 (1982), 505–520.
2. Anders, S., Huber, W., Differential expression analysis for sequence count data. Genome Biol., 11, 2010, R106.
3. Asrih, M., Jornayvaz, F.R., Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J. Endocrinol. 218 (2013), R25–R36.
4. Astrup, A., Meinert Larsen, T., Harper, A., Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?. Lancet 364 (2004), 897–899.
5. Aufreiter, S., Gregory, J.F. 3rd, Pfeiffer, C.M., Fazili, Z., Kim, Y.I., Marcon, N., Kamalaporn, P., Pencharz, P.B., O'Connor, D.L., Folate is absorbed across the colon of adults: evidence from cecal infusion of (13)C-labeled [6S]-5-formyltetrahydrofolic acid. Am. J. Clin. Nutr. 90 (2009), 116–123.
6. Badman, M.K., Kennedy, A.R., Adams, A.C., Pissios, P., Maratos-Flier, E., A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss. Am. J. Physiol. Endocrinol. Metab. 297 (2009), E1197–E1204.
7. Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S., Maratos-Flier, E., Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007), 426–437.
8. Bal, B.S., Finelli, F.C., Shope, T.R., Koch, T.R., Nutritional deficiencies after bariatric surgery. Nat. Rev. Endocrinol. 8 (2012), 544–556.
9. Bartoń K. (2016). MuMIn: multi-model inference. R package, version 1.15.6. https://CRAN.R-project.org/package=MuMIn.
10. Bates, D., Mächler, M., Bolker, B., Walker, S., Fitting linear mixed-effects models using lme4. J. Stat. Software, 67, 2015, 10.18637/jss.v067.i01.
11. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B 57 (1995), 289–300.
12. Bian, H., Hakkarainen, A., Lundbom, N., Yki-Jarvinen, H., Effects of dietary interventions on liver volume in humans. Obesity 22 (2014), 989–995.
13. Braunersreuther, V., Viviani, G.L., Mach, F., Montecucco, F., Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J. Gastroenterol. 18 (2012), 727–735.
14. Bray, N.L., Pimentel, H., Melsted, P., Pachter, L., Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34 (2016), 525–527.
15. Breheny, P., and Burchett, W. (2016). Visualization of regression models using visreg. Version 2.3.0. https://CRAN.R-project.org/package=visreg.
16. Browning, J.D., Baker, J.A., Rogers, T., Davis, J., Satapati, S., Burgess, S.C., Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 93 (2011), 1048–1052.
17. Browning, J.D., Davis, J., Saboorian, M.H., Burgess, S.C., A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content. Hepatology 44 (2006), 487–488.
18. Brugger, B., Erben, G., Sandhoff, R., Wieland, F.T., Lehmann, W.D., Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 94 (1997), 2339–2344.
19. Chakravarthy, M.V., Pan, Z., Zhu, Y., Tordjman, K., Schneider, J.G., Coleman, T., Turk, J., Semenkovich, C.F., “New” hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1 (2005), 309–322.
20. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M., Sanyal, A.J., The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Am. J. Gastroenterol. 107 (2012), 811–826.
21. Chen, R., Mias, G.I., Li-Pook-Than, J., Jiang, L., Lam, H.Y., Chen, R., Miriami, E., Karczewski, K.J., Hariharan, M., Dewey, F.E., et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148 (2012), 1293–1307.
22. Christensen, K.E., Wu, Q., Wang, X., Deng, L., Caudill, M.A., Rozen, R., Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J. Nutr. 140 (2010), 1736–1741.
23. Christodoulides, C., Dyson, P., Sprecher, D., Tsintzas, K., Karpe, F., Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J. Clin. Endocrinol. Metab. 94 (2009), 3594–3601.
24. Crawford, P.A., Crowley, J.R., Sambandam, N., Muegge, B.D., Costello, E.K., Hamady, M., Knight, R., Gordon, J.I., Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc. Natl. Acad. Sci. USA 106 (2009), 11276–11281.
25. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
26. Diraison, F., Moulin, P., Beylot, M., Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29 (2003), 478–485.
27. Diraison, F., Pachiaudi, C., Beylot, M., In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: determination of the average number of deuterium atoms incorporated. Metabolism 45 (1996), 817–821.
28. Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D., Parks, E.J., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005), 1343–1351.
29. Ducker, G.S., Rabinowitz, J.D., One-carbon metabolism in health and disease. Cell Metab. 25 (2017), 27–42.
30. Duncan, S.H., Belenguer, A., Holtrop, G., Johnstone, A.M., Flint, H.J., Lobley, G.E., Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73 (2007), 1073–1078.
31. Dushay, J., Chui, P.C., Gopalakrishnan, G.S., Varela-Rey, M., Crawley, M., Fisher, F.M., Badman, M.K., Martinez-Chantar, M.L., Maratos-Flier, E., Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139 (2010), 456–463.
32. Fabbrini, E., Sullivan, S., Klein, S., Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51 (2010), 679–689.
33. Foster, G.D., Wyatt, H.R., Hill, J.O., McGuckin, B.G., Brill, C., Mohammed, B.S., Szapary, P.O., Rader, D.J., Edman, J.S., Klein, S., A randomized trial of a low-carbohydrate diet for obesity. N. Engl. J. Med. 348 (2003), 2082–2090.
34. Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R.A., Bugianesi, E., Gastaldelli, A., Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5 (2013), 1544–1560.
35. Gambino, R., Musso, G., Cassader, M., Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 15 (2011), 1325–1365.
36. Ginsberg, H.N., Le, N.A., Goldberg, I.J., Gibson, J.C., Rubinstein, A., Wang-Iverson, P., Norum, R., Brown, W.V., Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78 (1986), 1287–1295.
37. Haas, J.T., Francque, S., Staels, B., Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu. Rev. Physiol. 78 (2016), 181–205.
38. Halsted, C.H., Villanueva, J.A., Devlin, A.M., Niemela, O., Parkkila, S., Garrow, T.A., Wallock, L.M., Shigenaga, M.K., Melnyk, S., James, S.J., Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc. Natl. Acad. Sci. USA 99 (2002), 10072–10077.
39. Hirsch, S., Poniachick, J., Avendano, M., Csendes, A., Burdiles, P., Smok, G., Diaz, J.C., de la Maza, M.P., Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition 21 (2005), 137–141.
40. Hong, S., Moreno-Navarrete, J.M., Wei, X., Kikukawa, Y., Tzameli, I., Prasad, D., Lee, Y., Asara, J.M., Fernandez-Real, J.M., Maratos-Flier, E., et al. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat. Med. 21 (2015), 887–894.
41. Kanehisa, M., Goto, S., KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000), 27–30.
42. Karlsson, F.H., Nookaew, I., Nielsen, J., Metagenomic data utilization and analysis (MEDUSA) and construction of a global gut microbial gene catalogue. PLoS Comput. Biol., 10, 2014, e1003706.
43. Kekwick, A., Pawan, G.L., Calorie intake in relation to body-weight changes in the obese. Lancet 271 (1956), 155–161.
44. Kelley, B., Totter, J.R., Day, P.L., The lipotropic effect of folic acid on rats receiving various purified diets. J. Biol. Chem. 187 (1950), 529–535.
45. Keogh, J.B., Brinkworth, G.D., Noakes, M., Belobrajdic, D.P., Buckley, J.D., Clifton, P.M., Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am. J. Clin. Nutr. 87 (2008), 567–576.
46. Kersten, S., Integrated physiology and systems biology of PPARalpha. Mol. Metab. 3 (2014), 354–371.
47. Kim, T.H., Yang, J., Darling, P.B., O'Connor, D.L., A large pool of available folate exists in the large intestine of human infants and piglets. J. Nutr. 134 (2004), 1389–1394.
48. Kindt, R., Coe, R., Tree Diversity Analysis. A Manual and Software for Common Statistical Methods for Ecological and Biodiversity Studies. 2005, World Agroforestry Centre.
49. Kolb, A.F., Petrie, L., Folate deficiency enhances the inflammatory response of macrophages. Mol. Immunol. 54 (2013), 164–172.
50. Korem, T., Zeevi, D., Suez, J., Weinberger, A., Avnit-Sagi, T., Pompan-Lotan, M., Matot, E., Jona, G., Harmelin, A., Cohen, N., et al. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples. Science 349 (2015), 1101–1106.
51. Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L.M., Lundbom, N., Rissanen, A., Ridderstrale, M., Groop, L., et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137 (2009), 865–872.
52. Laeger, T., Henagan, T.M., Albarado, D.C., Redman, L.M., Bray, G.A., Noland, R.C., Munzberg, H., Hutson, S.M., Gettys, T.W., Schwartz, M.W., et al. FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 124 (2014), 3913–3922.
53. Le Roy, T., Llopis, M., Lepage, P., Bruneau, A., Rabot, S., Bevilacqua, C., Martin, P., Philippe, C., Walker, F., Bado, A., et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62 (2013), 1787–1794.
54. LeBlanc, J.G., Laino, J.E., del Valle, M.J., Vannini, V., van Sinderen, D., Taranto, M.P., de Valdez, G.F., de Giori, G.S., Sesma, F., B-group vitamin production by lactic acid bacteria–current knowledge and potential applications. J. Appl. Microbiol. 111 (2011), 1297–1309.
55. Lee, S., Zhang, C., Kilicarslan, M., Piening, B.D., Bjornson, E., Hallstrom, B.M., Groen, A.K., Ferrannini, E., Laakso, M., Snyder, M., et al. Integrated network analysis reveals an association between plasma mannose levels and insulin resistance. Cell Metab. 24 (2016), 172–184.
56. Leung, C., Rivera, L., Furness, J.B., Angus, P.W., The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 412–425.
57. Lewis, G.F., Carpentier, A., Adeli, K., Giacca, A., Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23 (2002), 201–229.
58. Li, H., Fang, Q., Gao, F., Fan, J., Zhou, J., Wang, X., Zhang, H., Pan, X., Bao, Y., Xiang, K., et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J. Hepatol. 53 (2010), 934–940.
59. Li, H., Zhang, J., Jia, W., Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Front. Med. 7 (2013), 25–30.
60. Lips, M.A., de Groot, G.H., Berends, F.J., Wiezer, R., van Wagensveld, B.A., Swank, D.J., Luijten, A., van Dijk, K.W., Pijl, H., Jansen, P.L., et al. Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects. Clin. Endocrinol. (Oxf.) 81 (2014), 862–870.
61. Lofgren, L., Forsberg, G.B., Stahlman, M., The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue. Sci. Rep., 6, 2016, 27688.
62. Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P., Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig. Liver Dis. 47 (2015), 181–190.
63. Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P.S., Caussy, C., Bettencourt, R., Highlander, S.K., et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 25 (2017), 1054–1062.e5.
64. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
65. Lundbom, J., Hakkarainen, A., Soderlund, S., Westerbacka, J., Lundbom, N., Taskinen, M.R., Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat. NMR Biomed. 24 (2011), 238–245.
66. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., Walley, A.J., Froguel, P., Carlsson, L.M., Uhlen, M., et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol., 9, 2013, 649.
67. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Uhlen, M., Nielsen, J., Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease. Nat. Commun., 5, 2014, 3083.
68. Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., Soderlund, S., Stahlman, M., Adiels, M., Hakkarainen, A., Lundbom, N., Kilicarslan, M., et al. Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD. Mol. Syst. Biol., 13, 2017, 916.
69. Mardinoglu, A., Shoaie, S., Bergentall, M., Ghaffari, P., Zhang, C., Larsson, E., Backhed, F., Nielsen, J., The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol. Syst. Biol., 11, 2015, 834.
70. Marengo, A., Rosso, C., Bugianesi, E., Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu. Rev. Med. 67 (2016), 103–117.
71. McGarry, J.D., Mannaerts, G.P., Foster, D.W., A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest. 60 (1977), 265–270.
72. McMurdie, P.J., Holmes, S., phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One, 8, 2013, e61217.
73. Murphy, R.C., James, P.F., McAnoy, A.M., Krank, J., Duchoslav, E., Barkley, R.M., Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal. Biochem. 366 (2007), 59–70.
74. Nguyen, D., Samson, S.L., Reddy, V.T., Gonzalez, E.V., Sekhar, R.V., Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: novel protective role of glutathione. Aging Cell 12 (2013), 415–425.
75. Noakes, M., Keogh, J.B., Foster, P.R., Clifton, P.M., Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am. J. Clin. Nutr. 81 (2005), 1298–1306.
76. Nuttall, F.Q., Gannon, M.C., The metabolic response to a high-protein, low-carbohydrate diet in men with type 2 diabetes mellitus. Metabolism 55 (2006), 243–251.
77. Paredes-Turrubiarte, G., Gonzalez-Chavez, A., Perez-Tamayo, R., Salazar-Vazquez, B.Y., Hernandez, V.S., Garibay-Nieto, N., Fragoso, J.M., Escobedo, G., Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Clin. Exp. Med. 16 (2016), 193–202.
78. Pawlak, M., Lefebvre, P., Staels, B., Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J. Hepatol. 62 (2015), 720–733.
79. Petersen, K.F., Dufour, S., Savage, D.B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G.W., Befroy, D., Zemany, L., Kahn, B.B., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 104 (2007), 12587–12594.
80. Petersen, M.C., Vatner, D.F., Shulman, G.I., Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13 (2017), 572–587.
81. Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C.A., Neubauer, S., Karpe, F., Hodson, L., Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men. J. Clin. Endocrinol. Metab. 100 (2015), 4425–4433.
82. Price, N.D., Magis, A.T., Earls, J.C., Glusman, G., Levy, R., Lausted, C., McDonald, D.T., Kusebauch, U., Moss, C.L., Zhou, Y., et al. A wellness study of 108 individuals using personal, dense, dynamic data clouds. Nat. Biotechnol. 35 (2017), 747–756.
83. Rinella, M.E., Sanyal, A.J., Management of NAFLD: a stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13 (2016), 196–205.
84. Rossi, M., Amaretti, A., Raimondi, S., Folate production by probiotic bacteria. Nutrients 3 (2011), 118–134.
85. Roza, A.M., Shizgal, H.M., The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass. Am. J. Clin. Nutr. 40 (1984), 168–182.
86. Sid, V., Siow, Y.L., O, K., Role of folate in nonalcoholic fatty liver disease. Can. J. Physiol. Pharmacol. 95 (2017), 1141–1148.
87. Sid, V., Wu, N., Sarna, L.K., Siow, Y.L., House, J.D., O, K., Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 (2015), R1215–R1225.
88. Singh, A., Gautier, B., Shannon, C.P., Vacher, M., Rohart, F., Tebutt, S.J., Le Cao, K.-A., DIABLO - an integrative, multi-omics, multivariate method for multi-group classification. bioRxiv, 2016, 10.1101/067611.
89. Solga, S., Alkhuraishe, A.R., Clark, J.M., Torbenson, M., Greenwald, A., Diehl, A.M., Magnuson, T., Dietary composition and nonalcoholic fatty liver disease. Dig. Dis. Sci. 49 (2004), 1578–1583.
90. Ståhlman, M., Davidsson, P., Kanmert, I., Rosengren, B., Borén, J., Fagerberg, B., Camejo, G., Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J. Lipid Res. 49 (2008), 481–490.
91. Stefan, N., Kantartzis, K., Haring, H.U., Causes and metabolic consequences of fatty liver. Endocr. Rev. 29 (2008), 939–960.
92. Strozzi, G.P., Mogna, L., Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J. Clin. Gastroenterol. 42:Suppl. 3 Pt 2 (2008), S179–S184.
93. Sugahara, H., Odamaki, T., Hashikura, N., Abe, F., Xiao, J.Z., Differences in folate production by bifidobacteria of different origins. Biosci. Microbiota Food Health 34 (2015), 87–93.
94. Targher, G., Byrne, C.D., Lonardo, A., Zoppini, G., Barbui, C., Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J. Hepatol. 65 (2016), 589–600.
95. Taskinen, M.R., Kuusi, T., Helve, E., Nikkila, E.A., Yki-Jarvinen, H., Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8 (1988), 168–177.
96. R Core Team, R: A Language and Environment for Statistical Computing. 2015, R Foundation for Statistical Computing.
97. Tryndyak, V., de Conti, A., Kobets, T., Kutanzi, K., Koturbash, I., Han, T., Fuscoe, J.C., Latendresse, J.R., Melnyk, S., Shymonyak, S., et al. Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism. FASEB J. 26 (2012), 4592–4602.
98. Wallner, S., Schmitz, G., Plasmalogens the neglected regulatory and scavenging lipid species. Chem. Phys. Lipids 164 (2011), 573–589.
99. Wang, Y., Viscarra, J., Kim, S.J., Sul, H.S., Transcriptional regulation of hepatic lipogenesis. Nat. Rev. Mol. Cell Biol. 16 (2015), 678–689.
100. Wichmann, A., Allahyar, A., Greiner, T.U., Plovier, H., Lundén, G.O., Larsson, T., Drucker, D.J., Delzenne, N.M., Cani, P.D., Backhed, F., Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14 (2013), 582–590.
101. Wieckowska, A., Papouchado, B.G., Li, Z., Lopez, R., Zein, N.N., Feldstein, A.E., Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103 (2008), 1372–1379.
102. Witthöft, C.M., Forssén, K., Johannesson, L., Jägerstad, M., Folates - food sources, analyses, retention and bioavailability. Scand. J. Nutr. 43 (1999), 138–146.
103. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
104. Wu, H., Esteve, E., Tremaroli, V., Khan, M.T., Caesar, R., Manneras-Holm, L., Stahlman, M., Olsson, L.M., Serino, M., Planas-Felix, M., et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23 (2017), 850–858.
105. Wu, H., Tremaroli, V., Backhed, F., Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol. Metab. 26 (2015), 758–770.
106. Wycherley, T.P., Brinkworth, G.D., Keogh, J.B., Noakes, M., Buckley, J.D., Clifton, P.M., Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J. Intern. Med. 267 (2010), 452–461.
107. Xia, M.F., Bian, H., Zhu, X.P., Yan, H.M., Chang, X.X., Zhang, L.S., Lin, H.D., Hu, X.Q., Gao, X., Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. Clin. Nutr., 2017, 10.1016/j.clnu.2017.06.021.
108. Young, M.D., Wakefield, M.J., Smyth, G.K., Oshlack, A., Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol., 11, 2010, R14.
109. Zhou, D., Pan, Q., Shen, F., Cao, H.X., Ding, W.J., Chen, Y.W., Fan, J.G., Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci. Rep., 7, 2017, 1529.